Expensive Gene Therapy For Retinal Diseases Raises Hopes And Concerns.

The Wall Street Journal (9/24, Reddy, Subscription Publication) reports patients with rare retinal diseases caused by a mutated RPE65 gene are hopeful that the new gene therapy Luxturna (voretigene neparvovec) could cure them, but many are also concerned...